Abstract
Serum cholesterol and triglyceride elevate with age until middle generation, and decline in old age. This change is partly accounted for by the change of endogenous sex hormones, especially in women. The incidence of dyslipidemia is not different between people of middle age and old age. However, the treatment is not the same in the two age groups. This is based on the idea that the impact of hyperlipidemia declines with age. There are some reports in which the significance of treatment of hyperlipidemia was examined: statin treatment appears beneficial for young-old people, while treatment of hyperlipidemia appears no longer beneficial for old-old people. Prospective study is needed before understanding the necessity of the treatment of hyperlipidemia in the old-old people.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
